Takeda Statementshttp://www.asiamerlion.cn/Takeda newsroom statementsenhttp://www.asiamerlion.cn/newsroom/statements/2021/remembering-tadataka-tachi-yamada/http://www.asiamerlion.cn/newsroom/statements/2021/remembering-tadataka-tachi-yamada/ Remembering Tadataka “Tachi” YamadaWed, 11 Aug 2021 12:00:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2021/revision-of-takedas-executive-compensation-overview/http://www.asiamerlion.cn/newsroom/statements/2021/revision-of-takedas-executive-compensation-overview/ Revision of Takeda’s Executive Compensation OverviewFri, 06 Aug 2021 08:00:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2021/european-patient-survey-crohns-disease/http://www.asiamerlion.cn/newsroom/statements/2021/european-patient-survey-crohns-disease/ European Patient Survey finds Crohn’s Disease Patients Living with Perianal Fistulas Experience a More Significant Negative Impact on Their Quality of Life than Crohn’s Disease Patients without Perianal Fistulas?Thu, 08 Jul 2021 22:00:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2021/takeda-provides-status-update-on-natpara-us-recall/http://www.asiamerlion.cn/newsroom/statements/2021/takeda-provides-status-update-on-natpara-us-recall/ Takeda Provides Status Update on NATPARA US RecallWed, 31 Mar 2021 12:30:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2021/takeda-builds-on-30-year-partnership-with-the-world-federation-of-hemophilia-with-a-five-year-product-donation-to-the-humanitarian-aid-program/http://www.asiamerlion.cn/newsroom/statements/2021/takeda-builds-on-30-year-partnership-with-the-world-federation-of-hemophilia-with-a-five-year-product-donation-to-the-humanitarian-aid-program/ Takeda Builds on 30-Year Partnership with the World Federation of Hemophilia with a Five-Year Product Donation to the Humanitarian Aid ProgramMon, 29 Mar 2021 11:00:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2021/takeda-announces-strategic-partnership-to-accelerate-the-development-of-enzyres-diagnostic-technology-platform-that-aims-to-improve-the-standard-of-care-for-patients-with-bleeding-disorders/http://www.asiamerlion.cn/newsroom/statements/2021/takeda-announces-strategic-partnership-to-accelerate-the-development-of-enzyres-diagnostic-technology-platform-that-aims-to-improve-the-standard-of-care-for-patients-with-bleeding-disorders/ Takeda Announces Strategic Partnership to Accelerate the Development of Enzyre’s Diagnostic Technology Platform That Aims to Improve the Standard of Care for Patients with Bleeding DisordersThu, 04 Mar 2021 08:00:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2020/update-on-the-u.s.-development-program-for-the-investigational-subcutaneous-formulation-of-entyvio-vedolizumab-as-a-maintenance-therapy-in-adults-with-moderate-to-severe-ulcerative-colitis/http://www.asiamerlion.cn/newsroom/statements/2020/update-on-the-u.s.-development-program-for-the-investigational-subcutaneous-formulation-of-entyvio-vedolizumab-as-a-maintenance-therapy-in-adults-with-moderate-to-severe-ulcerative-colitis/ Update on the U.S. Development Program for the Investigational Subcutaneous Formulation of ENTYVIO? (vedolizumab) as a Maintenance Therapy in Adults with Moderate to Severe Ulcerative ColitisTue, 01 Sep 2020 21:00:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2020/update-of-the-financial-impact-of-the-european-commissions-decision-to-release-takeda-from-commitment-to-divest-shires-pipeline-compound-shp647/http://www.asiamerlion.cn/newsroom/statements/2020/update-of-the-financial-impact-of-the-european-commissions-decision-to-release-takeda-from-commitment-to-divest-shires-pipeline-compound-shp647/ Update of the Financial Impact of the European Commission’s Decision to Release Takeda from Commitment to Divest Shire’s Pipeline Compound SHP647Mon, 22 Jun 2020 08:30:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2020/regarding-a-warning-letter-from-the-u.s.-food-and-drug-administration/http://www.asiamerlion.cn/newsroom/statements/2020/regarding-a-warning-letter-from-the-u.s.-food-and-drug-administration/ Regarding a Warning Letter from the U.S. Food and Drug AdministrationWed, 17 Jun 2020 05:00:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2019/takeda-provides-update-on-tourmaline-al1-phase-3-trial/http://www.asiamerlion.cn/newsroom/statements/2019/takeda-provides-update-on-tourmaline-al1-phase-3-trial/ Takeda Provides Update on TOURMALINE-AL1 Phase 3 Trial in AL AmyloidosisWed, 05 Jun 2019 20:30:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2019/takeda-notes-court-sanction-of-the-scheme-of-arrangement-with-respect-to--the-acquisition-of-shire-plc/http://www.asiamerlion.cn/newsroom/statements/2019/takeda-notes-court-sanction-of-the-scheme-of-arrangement-with-respect-to--the-acquisition-of-shire-plc/ Takeda Notes Court Sanction of the Scheme of Arrangement with respect to the Acquisition of Shire plcThu, 03 Jan 2019 12:57:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2018/TakedacommentsonongoingPhase1reviewbytheEuropeanCommissionoftheproposedacquisitionofShireplc/http://www.asiamerlion.cn/newsroom/statements/2018/TakedacommentsonongoingPhase1reviewbytheEuropeanCommissionoftheproposedacquisitionofShireplc/ Takeda comments on ongoing Phase 1 review by the European Commission of the proposed acquisition of Shire plcFri, 26 Oct 2018 20:00:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2018/takeda-statement-regarding-press-reports2/http://www.asiamerlion.cn/newsroom/statements/2018/takeda-statement-regarding-press-reports2/ Takeda Statement Regarding Press ReportsTue, 08 May 2018 03:00:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2018/takeda-statement-regarding-shire-plc2/http://www.asiamerlion.cn/newsroom/statements/2018/takeda-statement-regarding-shire-plc2/ Takeda Statement Regarding Shire plcTue, 24 Apr 2018 13:30:00 Zhttp://www.asiamerlion.cn/newsroom/statements/2018/statement-regarding-improved-proposal-for-shire/http://www.asiamerlion.cn/newsroom/statements/2018/statement-regarding-improved-proposal-for-shire/ Takeda Statement Regarding Improved Proposal for Shire plcFri, 20 Apr 2018 04:00:00 Z国产AV网站_中午文字幕av一区二区三区_性进入裸体视频_久久久久久精品免费免费直播